Mufan Xu

Mufan Xu has a diverse work experience in the field of biotechnology and clinical research. Starting from 2015, Mufan worked as a Clinical Laboratory Intern at CapitalCare Pediatrics of Clifton Park. In 2016, they worked as a Laboratory Assistant at Northeastern University Department of Biology. The following year, Mufan became a Research Assistant at the Rosengaus Lab at Northeastern University and later at the Chai Lab at Northeastern University in 2018. In the same year, they also gained experience as a Virology Research Intern at Sanofi Pasteur.

Continuing their career progression, Mufan worked as a CMC Bioassay Co-op at Surface Oncology Inc. in 2019. The next year, they pursued a Co-op opportunity as a Clinical Operations Co-op at Acceleron Pharma. In 2021, Mufan became a Research Associate in BAPK at Acceleron Pharma before moving to Ring Therapeutics in 2022 as a Research Associate II in Biophysical Analytical Development. Mufan then transitioned to the role of Research Associate I in Biophysical Analytical Development, before eventually joining Entrada Therapeutics in 2023 as a Research Associate II in Bioanalytical Product Development.

Overall, Mufan Xu has gained valuable experience in various research and development roles within the biotechnology industry, showcasing their growth and commitment to the field.

Mufan Xu's education history begins with their high school diploma from Niskayuna High School, which they obtained from 2012 to 2016. Following that, Mufan pursued a Bachelor's degree in Biochemistry, first at Northeastern University from 2016 to 2021, and then at The University of Queensland for a brief period in 2020.